Screening newborns for inborn errors of metabolism by tandem mass spectrometry

New England Journal of Medicine

Volumn 348, Issue 23, 2003, Pages 2304-2312

  Wilcken, Bridget ^a,b,c,d   Wiley, Veronica ^a,c   Hammond, Judith ^b,c   Carpenter, Kevin ^b,c  

^a New S Wales Newborn Screening Prog   (Australia)

^b Long Bay Correctional Complex   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARBOXYLIC ACID; FATTY ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME DEFICIENCY; FATTY ACID OXIDATION; HUMAN; INBORN ERROR OF METABOLISM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PHENYLKETONURIA; PREVALENCE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UREA CYCLE;

AUSTRALIAN CAPITAL TERRITORY; COHORT STUDIES; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; METABOLISM, INBORN ERRORS; NEONATAL SCREENING; NEW SOUTH WALES; PREVALENCE;

EID: 0037685217     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa025225     Document Type: Article

References (26)

1. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991;66:29-33.
2. Farreli PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001;107:1-13.
3. U.S. Congress, Office of Technology Assessment. Healthy children: investing in the future. Washington, D.C.: Government Printing Office, 1988. (Publication no. OTAH-345.)
4. Lees CM, Davies S, Dezateux C. Neonatal screening for sickle cell disease. Cochrane Database Syst Rev 2000;2:CD001913.
5. Wilcken B. Rare diseases and the assessment of intervention: what sorts of clinical trials can we use? J Inherit Metab Dis 2001; 24:291-8.
6. Albers S, Marsden D, Quackenbush E, Stark AR, Levy HL, Irons M. Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry. Pediatrics 2001;107:1417. abstract.
7. Ranieri E, Gerace R, Bartlett B, Barnard K, Fletcher JM. The introduction of tandem mass spectrometry into the South Australian Neonatal Screening Programme: benefits and costs. J Inherit Metab Dis 2000;23:Suppl 1:3. abstract.
8. Roscher A, Liebl B, Fingerhut R, Olgemöller B. Prospective study of MS-MS newborn screening in Bavaria, Germany: interim results. J Inherit Metab Dis 2000;23:Suppl 1:4. abstract.
9. Wilcken B, Wiley V, Carpenter K. Two years of routine newborn screening by tandem mass spectrometry (MSMS) in New South Wales, Australia. T Inherit Metab Dis 2000;23:Suppl 1:4. abstract.
10. Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr 2001;138: 581-4.
11. Wiley V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr Suppl 1999;88:45-51.
12. Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47: 1945-55.
13. Wood JC, Magera MJ, Rinaldo P, Seashore MR, Strauss AW, Friedman A. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card. Pediatrics 2001;108:173-4. abstract.
14. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
15. Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 2001;47:2040-4.
16. Marshall E. Fast technology drives new world of newborn screening. Science 2001; 294:2272-4. [Erratum, Science 2002;295:2370.]
17. Rhead WJ, Allain D, Van Calcar S, et al. Short chain acyl-CoA dehydrogenase (SCAD) and 3-methylcrotonyl-CoA carboxylase (MCC) deficiencies: tandem mass spectrometry newborn screening detects many clinically benign cases. J Inherit Metab Dis 2002;25: Suppl 1:4. abstract.
18. Gibson KM, Bennett MJ, Naylor EW, Morton DH. 3-Methylcrotonyl-coenzyme A carboxylase deficiency in Amish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr 1998;132:519-23.
19. Iafolla AK, Thompson RJ Jr, Roe CR, Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994;124:409-15.
20. Leung KC, Hammond JW, Chabra S, Carpenter KH, Potter M, Wilcken B. A fatal neonatal case of medium-chain acyl-coenzyme A dehydrogenase deficiency with homozygous A→G985 transition. J Pediatr 1992;121: 965-8.
21. Heptinstall LE, Till J, Wraith JE, Besley GT. Common MCAD mutation in a healthy parent of two affected siblings. J Inherit Metab Dis 1995;18:638-9.
22. Pourfarzam M, Morris A, Appleton M, Craft A, Bartlett K. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency. Lancet 2001;358:1063-4.
23. Andresen BS, Dobrowolski SF, O'Reilly L, et al. The mutational spectrum in the MCAD gene of newborns identified by prospective tandem MS screening for "diagnostic" acyl-carnitines in blood spots differs from that observed in clinically affected patients. J Inherit Metab Dis 2000;23:Suppl 1:12. abstract.
24. Carpenter K, Wiley V, Sim KG, Heath D, Wilcken B. Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies. Arch Dis Child Fetal Neonatal Ed 2001;85:F105-F109.
25. Schulze A, Frommhold D, Hoffmann GF, Mayatepek E. Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I. Clin Chem 2001;47:1424-9.
26. Peterschmitt MJ, Simmons JR, Levy HL. Reduction of false negative results in screening of newborns for homocystinuria. N Engl J Med 1999;341:1572-6.